Breaking News
Get 50% Off 0
🌎 30+ NEW AI-picked stock strategies for exciting international markets
Unlock Global AI Picks

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Here's Why You Should Buy Reliance Steel (RS) Stock Right Now By Zacks Investment Research - Jan 05, 2022

Reliance Steel & Aluminum Co. RS is benefiting from strong demand across key end-use markets, a diversified product base and strategic acquisitions. Shares of the company have risen 24.8% in the...

HCA Healthcare (HCA) Buys MD Now, Boosts Florida Presence By Zacks Investment Research - Jan 05, 2022

HCA Healthcare (NYSE:HCA), Inc. HCA recently announced that it has acquired MD Now Urgent Care from a LA-based private equity investment firm, Brentwood Associates. The transaction was closed at...

Should You Bet on Cathie Wood in 2022? By Zacks Investment Research - Jan 05, 2022

(1:00) - Breaking Down ARK Invest's Performance In 2021(12:30) - Gaining Exposure To High Flying Tech Stocks(16:00) - Will Inflows Impact How Cathie Woods Will Invest Going Forward?(22:20) - Learning...

Will REX (REX) Gain on Rising Earnings Estimates? By Zacks Investment Research - Jan 05, 2022

REX (REX) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts...

Here's Why You Should Retain Cardinal Health (CAH) Stock Now By Zacks Investment Research - Jan 04, 2022

Cardinal Health Inc (NYSE:CAH). CAH is well-poised for growth on the back of a diversified product portfolio, acquisition-driven strategy and robust pharmaceutical segment. However, margin contraction...

AbbVie (ABBV) Gets FDA Breakthrough Tag for Lung Cancer Drug By Zacks Investment Research - Jan 04, 2022

AbbVie ABBV announced that the FDA has granted a Breakthrough Therapy Designation (BTD) to its investigational antibody-drug conjugate (ADC) telisotuzumab vedotin (Teliso-V) for previously treated...

Top Stock Picks for Week of January 3, 2022 By Zacks Investment Research - Jan 04, 2022

Broadridge Financial Solutions (NYSE:BR), Inc. BR is a global fintech leader, provides investor communications and technology-driven solutions to banks, broker-dealers, mutual funds and corporate...

Continue with Apple
Continue with Google
or
Sign up with Email